These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 3071531)
21. Poststatin, a new inhibitor of prolyl endopeptidase. V. Endopeptidase inhibitory activity of poststatin analogues. Tsuda M; Muraoka Y; Nagai M; Aoyagi T; Takeuchi T J Antibiot (Tokyo); 1996 Sep; 49(9):890-9. PubMed ID: 8931723 [TBL] [Abstract][Full Text] [Related]
22. ZTTA, a postproline cleaving enzyme inhibitor, improves cerebral ischemia-induced deficits in a three-panel runway task in rats. Shishido Y; Furushiro M; Tanabe S; Nishiyama S; Hashimoto S; Ohno M; Yamamoto T; Watanabe S Pharmacol Biochem Behav; 1996 Nov; 55(3):333-8. PubMed ID: 8951974 [TBL] [Abstract][Full Text] [Related]
23. New prolyl oligopeptidase inhibitors developed from dicarboxylic acid bis(l-prolyl-pyrrolidine) amides. Wallén EA; Christiaans JA; Jarho EM; Forsberg MM; Venäläinen JI; Männistö PT; Gynther J J Med Chem; 2003 Oct; 46(21):4543-51. PubMed ID: 14521416 [TBL] [Abstract][Full Text] [Related]
24. Poststatin, a new inhibitor of prolyl endopeptidase. VII. N-cycloalkylamide analogues. Tsuda M; Muraoka Y; Nagai M; Aoyagi T; Takeuchi T J Antibiot (Tokyo); 1996 Sep; 49(9):909-20. PubMed ID: 8931725 [TBL] [Abstract][Full Text] [Related]
26. [(S)-gamma-(Arylamino)prolyl]thiazolidine compounds as a novel series of potent and stable DPP-IV inhibitors. Sakashita H; Akahoshi F; Kitajima H; Tsutsumiuchi R; Hayashi Y Bioorg Med Chem; 2006 Jun; 14(11):3662-71. PubMed ID: 16460948 [TBL] [Abstract][Full Text] [Related]
27. cDNA cloning of mouse prolyl endopeptidase and its involvement in DNA synthesis by Swiss 3T3 cells. Ishino T; Ohtsuki S; Homma Ki; Natori S J Biochem; 1998 Mar; 123(3):540-5. PubMed ID: 9538240 [TBL] [Abstract][Full Text] [Related]
28. Dicarboxylic acid azacycle l-prolyl-pyrrolidine amides as prolyl oligopeptidase inhibitors and three-dimensional quantitative structure-activity relationship of the enzyme-inhibitor interactions. Jarho EM; Wallén EA; Christiaans JA; Forsberg MM; Venäläinen JI; Männistö PT; Gynther J; Poso A J Med Chem; 2005 Jul; 48(15):4772-82. PubMed ID: 16033257 [TBL] [Abstract][Full Text] [Related]
29. Benzyloxycarbonylprolylprolinal, a transition-state analogue for prolyl oligopeptidase, forms a tetrahedral adduct with catalytic serine, not a reactive cysteine. Kahyaoglu A; Haghjoo K; Kraicsovits F; Jordan F; Polgar L Biochem J; 1997 Mar; 322 ( Pt 3)(Pt 3):839-43. PubMed ID: 9148758 [TBL] [Abstract][Full Text] [Related]
30. S 17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase. Barelli H; Petit A; Hirsch E; Wilk S; De Nanteuil G; Morain P; Checler F Biochem Biophys Res Commun; 1999 Apr; 257(3):657-61. PubMed ID: 10208839 [TBL] [Abstract][Full Text] [Related]
31. Prolyl oligopeptidase inhibition-induced growth arrest of human gastric cancer cells. Suzuki K; Sakaguchi M; Tanaka S; Yoshimoto T; Takaoka M Biochem Biophys Res Commun; 2014 Jan; 443(1):91-6. PubMed ID: 24269815 [TBL] [Abstract][Full Text] [Related]
32. Poststatin, a new inhibitor of prolyl endopeptidase. VIII. Endopeptidase inhibitory activity of non-peptidyl poststatin analogues. Tsuda M; Muraoka Y; Nagai M; Aoyagi T; Takeuchi T J Antibiot (Tokyo); 1996 Oct; 49(10):1022-30. PubMed ID: 8968396 [TBL] [Abstract][Full Text] [Related]
33. Novel inhibitors of prolyl endopeptidase: effects of stereochemistry. Kolosko N; Bakker AV; Faraci WS; Nagel AA Drug Des Discov; 1994 Jan; 11(1):61-71. PubMed ID: 8068820 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and structure-activity relationships of peptidyl alpha-keto heterocycles as novel inhibitors of prolyl endopeptidase. Tsutsumi S; Okonogi T; Shibahara S; Ohuchi S; Hatsushiba E; Patchett AA; Christensen BG J Med Chem; 1994 Oct; 37(21):3492-502. PubMed ID: 7932578 [TBL] [Abstract][Full Text] [Related]
35. Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors. Venäläinen JI; Garcia-Horsman JA; Forsberg MM; Jalkanen A; Wallén EA; Jarho EM; Christiaans JA; Gynther J; Männistö PT Biochem Pharmacol; 2006 Feb; 71(5):683-92. PubMed ID: 16405869 [TBL] [Abstract][Full Text] [Related]
36. Purification and characterization of prolyl endopeptidase from pig brain. Schönlein C; Heins J; Barth A Biol Chem Hoppe Seyler; 1990 Dec; 371(12):1159-64. PubMed ID: 2090162 [TBL] [Abstract][Full Text] [Related]
37. Novel hepatitis C virus protease inhibitors: thiazolidine derivatives. Sudo K; Matsumoto Y; Matsushima M; Fujiwara M; Konno K; Shimotohno K; Shigeta S; Yokota T Biochem Biophys Res Commun; 1997 Sep; 238(2):643-7. PubMed ID: 9299567 [TBL] [Abstract][Full Text] [Related]
38. Studies on prolyl endopeptidase from shakashimeji (Lyophyllum cinerascens): purification and enzymatic properties. Yoshimoto T; Sattar AK; Hirose W; Tsuru D J Biochem; 1988 Oct; 104(4):622-7. PubMed ID: 3071534 [TBL] [Abstract][Full Text] [Related]
39. 4-Phenylbutanoyl-2(S)-acylpyrrolidines and 4-phenylbutanoyl-L-prolyl-2(S)-acylpyrrolidines as prolyl oligopeptidase inhibitors. Wallén EA; Christiaans JA; Saario SM; Forsberg MM; Venäläinen JI; Paso HM; Männistö PT; Gynther J Bioorg Med Chem; 2002 Jul; 10(7):2199-206. PubMed ID: 11983517 [TBL] [Abstract][Full Text] [Related]
40. Purification and characterization of a Z-pro-prolinal-insensitive Z-Gly-Pro-7-amino-4-methyl coumarin-hydrolyzing peptidase from bovine serum--a new proline-specific peptidase. Birney YA; O'Connor BF Protein Expr Purif; 2001 Jul; 22(2):286-98. PubMed ID: 11437605 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]